RNA therapeutics for regenerative medicine.

It is estimated that millions of people around the world experience various types of tissue injuries every year. Regenerative medicine was born and developed for understanding and application with the aim of replacing affected organs or some cells. The research, manufacture, production, and distribution of RNA in cells have acted as a basic foundation for the development and testing of therapies and treatments that are widely applied in different fields of medicine. Vaccines against COVID-19 are considered one of the brilliant and outstanding successes of RNA therapeutics research. With the characteristics of bio-derived RNA therapeutics, the mechanism of rapid implementation, safe production, and flexibility to create proteins depending on actual requirements. Based on the advantages above in this review, we discuss RNA therapeutics for regenerative medicine, and the types of RNA therapies currently being used for regenerative medicine. The relationship between disease and regenerative medicine is currently being studied or tested in RNA therapeutics. We have also covered the mechanisms of action of RNA therapy for regenerative medicine and some of the limitations in our current understanding of the effects of RNA therapy in this area. Additionally, we have also covered developing RNA therapeutics for regenerative medicine, focusing on RNA therapeutics for regenerative medicine. As a final point, we discuss potential applications for therapeutics for regenerative medicine in the future, as well as their mechanisms.

RNA therapeutics for the treatment of blood disorders.

Blood disorders are defined as diseases related to the structure, function, and formation of blood cells. These diseases lead to increased years of life loss, reduced quality of life, and increased financial burden for social security systems around the world. Common blood disorder treatments such as using chemical drugs, organ transplants, or stem cell therapy have not yet approached the best goals, and treatment costs are also very high. RNA with a research history dating back several decades has emerged as a potential method to treat hematological diseases. A number of clinical trials have been conducted to pave the way for the use of RNA molecules to cure blood disorders. This novel approach takes advantage of regulatory mechanisms and the versatility of RNA-based oligonucleotides to target genes and cellular pathways involved in the pathogenesis of specific diseases. Despite positive results, currently, there is no RNA drug to treat blood-related diseases approved or marketed. Before the clinical adoption of RNA-based therapies, challenges such as safe delivery of RNA molecules to the target site and off-target effects of injected RNA in the body need to be addressed. In brief, RNA-based therapies open novel avenues for the treatment of hematological diseases, and clinical trials for approval and practical use of RNA-targeted are crucial.

Phage for cancer therapy.

Cancer is currently a global health challenge, characterized by dysfunction of organs due to the uncontrolled growth of cells exponentially. The therapies used to treat cancer in patients so far are widely used. However, there are also some problems, such as the high cost of surgery and chemotherapy. Thus, there are many barriers to care for patients with cancer, especially in low and middle-income countries. In addition, the many risks and adverse effects of radiation treatment. Therefore, to reduce mortality in patients with the disease, we need a newer therapy with more targeted treatment, fewer side effects, and cheaper cost. The application of bacteria in cancer treatment was first developed in 1983. Currently, this therapy is attracting the attention of scientists due to its great potential in cancer treatment. This chapter discusses the successful research on the bacteriophage for cancer, the mechanism and its potential. In addition, some types of bacteria that are most important for cancer treatment and limitations on the widespread application of this therapy were also mentioned. Reviewing all the researches on bacteriotherapy in cancer are essential to increase the knowledge in this area and make this therapy more optimal in the future.

Epigenetics in cancer development, diagnosis and therapy.

Cancer is a dangerous disease and one of the leading causes of death in the world. In 2020, there were nearly 10 million cancer deaths and approximately 20 million new cases. New cases and deaths from cancer are expected to increase further in the coming years. To have a deeper insight into the mechanism of carcinogenesis, epigenetics studies have been published and received much attention from scientists, doctors, and patients. Among alterations in epigenetics, DNA methylation and histone modification are studied by many scientists. They have been reported to be a major contributor in tumor formation and are involved in metastasis. From the understanding of DNA methylation and histone modification, effective, accurate and cost-effective methods for diagnosis and screening of cancer patients have been introduced. Furthermore, therapeutic approaches and drugs targeting altered epigenetics have also been clinically studied and have shown positive results in combating tumor progression. Several cancer drugs that rely on DNA methylation inactivation or histone modification have been approved by the FDA for the treatment of cancer patients. In summary, epigenetics changes such as DNA methylation or histone modification are take part in tumor growth, and they also have great prospect to study diagnostic and therapeutic methods of this dangerous disease.

A review on the emerging applications of cellulose, cellulose derivatives and nanocellulose in carbon capture.

Carbon capture can be implemented at a large scale only if the CO2 selective materials are abundantly available at low cost. Since the sustainable requirement also elevated, the low-cost and biodegradable cellulosic materials are developed into CO2 selective adsorbent and membranes recently. The applications of cellulose, cellulosic derivatives and nanocellulose as CO2 selective adsorbents and membranes are reviewed here. The fabrication and modification strategies are discussed besides comparing their CO2 separation performance. Cellulose nanofibrils (CNFs) and cellulose nanocrystals (CNCs) isolated from cellulose possess a big surface area for mechanical enhancement and a great number of hydroxyl groups for modification. Nanocellulose aerogels with the large surface area were chemically modified to improve their selectivity towards CO2. Even with the reduction of surface area, amino-functionalized nanocellulose aerogels exhibited the satisfactory chemisorption of CO2 with a capacity of more than 2 mmol/g was recorded. Inorganic fillers such as silica, zeolite and MOFs were further incorporated into nanocellulose aerogels to enhance the physisorption of CO2 by increasing the surface area. Although CO2 adsorbents developed from cellulose and cellulose derivatives were less reported, their applications as the building blocks of CO2 separation membranes had been long studied. Cellulose acetate membranes were commercialized for CO2 separation, but their separation performance could be further improved with silane or inorganic filler. CNCs and CNFs enhanced the CO2 selectivity and permeance through polyvinyl alcohol coating on membranes, but only CNF membranes incorporated with MOFs were explored so far. Although some of these membranes surpassed the upper-bound of Robeson plot, their stability should be further investigated.

Bioelectrochemical technology for recovery of silver from contaminated aqueous solution: a review.

A large amount of silver-rich wastewater is generated from different industrial processes. This wastewater is not considered a waste, but a valuable source for recovery due to the precious silver (Ag). Previous studies have used traditional methods such as membrane filtration, electrolysis, chemical precipitation, electrochemical, and cementation for Ag recovery. However, many drawbacks have been reported for these techniques such as high cost, hazardous waste generation, and the needed refinement of recovered products. In this study, a bioelectrochemical system (BES) for Ag recovery from aqueous solution is introduced as an effective and innovative method, as compared with other techniques. Different types of Ag(I)-containing solutions that have been investigated in recent BES studies (e.g., Ag+ solution, [Ag(NH3)2]+, [Ag(S2O3)]-, [Ag(S2O3)2]3- complexes) are reported. A BES is an anaerobic system consisting of anode and cathode chambers, which are normally separated by an ion-exchange membrane. The electron flow obtained from the anodic biological oxidation of organic matter is used directly for the cathodic electrochemical reduction of Ag(I) ions. The recovered product is Ag electrodeposits, formed at the cathode surface. Several studies have reported high Ag recovery efficiency by using a BES (i.e., > 90%), with high purity of metallic silver, and simultaneous electricity production. Furthermore, a BES can be employed for a wide range of initial Ag(I) concentrations (e.g., 50-3000 mg/L). The advantages of BES technology for Ag recovery are highlighted in this study for further practical applications.

Electrochemical reduction of different Ag(i)-containing solutions in bioelectrochemical systems for recovery of silver and simultaneous power generation.

In this study, dual-chamber bioelectrochemical reactors (i.e., R1, R2, R3, and R4) were employed to investigate the Ag recovery and electricity production from different Ag(i)-containing artificial wastewaters (i.e., Ag+ solution, [Ag(NH3)2]+ and [Ag(S2O3)2]3- complexes, and mixed metal solution). Results showed that the electrochemical reductions of Ag(i) ions in all reactors were rapid reactions. The reaction rate in R1 was the fastest. At the same initial conditions (i.e. Ag(i) concentration of 1000-1080 mg L-1), the Ag recovery efficiency was 81.8% for R3 operated with the [Ag(S2O3)2]3- complex. Although high Ag removal efficiency (i.e., >99%) was found in other reactors, some diffusion of positively charged Ag(i) ions through the membrane was also observed along with the electrochemical reduction. In all cases, pure silver electrodeposits, mainly as dendrites and crystals in different morphologies, were observed at the cathode surfaces when characterized by SEM, EDX, and XRD. The performance of electricity production was evaluated by the open circuit voltage (OCV) and maximum power density (P max) obtained during the BES operation. Reactor R1 showed better performance (i.e., OCV of 828 mV, P max of 8258 mW m-3), due to its high standard reduction potential. The lower performance in other reactors was due to the complexity of solutions, other co-existing metals (mixed metal solution), and lower standard reduction potential. In general, the existing forms of Ag(i) in solutions affect the Ag(i) reduction rate. This further influences the Ag removal efficiency, morphology of electrodeposits, and power generation.

Factors influencing silver recovery and power generation in bio-electrochemical reactors.

The recovery of silver from Ag+ solution coupled with power generation was investigated in bio-electrochemical system (BES). In this system, chemical energy existing in the organic matter in the anode chamber can be converted biologically to electrical energy which can be used for the reduction of Ag+ ions in the cathode chamber. Results showed that type of substrate influenced the metabolic pathway and affected the cell voltage progression, and columbic efficiency. Silver recovery was not affected by increasing initial pH (2.0 to 7.0) and Ag+ concentration (100 to 1000 mg/L) in the catholyte, whereas power generation was improved. A maximum power density of 8258 mW/m3 and a columbic efficiency of 21.61% could be achieved with 1000 mg/L of Ag+. Ag+ ions were reduced to form metallic deposits as Ag0 crystals on the cathode surface, which were then confirmed by scanning electron microscope (SEM) image and energy dispersive X-ray (EDX) spectrum. The BES reactor had high silver removal (i.e., >96%) after 24 h of operation. When considering the crossover of Ag+ ions through the cation exchange membrane, the removal was in the range of 83.73-92.51%. This crossover was not considerable as compared to the Ag+ initial concentration. At higher initial Ag+ concentration (2000 mg/L), the silver removal decreased to 88.61% and the maximum power density decreased to 5396 mW/m3. This study clearly showed that BES can be employed for silver recovery, wastewater treatment, and also electricity generation.